Risperidone Dosing Pattern and Clinical Outcome in Psychosis: An Analysis of 1713 Cases
J Clin Psychiatry 2005;66(7):887-893
© Copyright 2017 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Background: In treating patients with psychosis,
practicing clinicians use various dosing strategies of
antipsychotic medications, including risperidone. To evaluate the
outcome of different risperidone dosing strategies in clinical
practice, we undertook a large, prospective, naturalistic study
in which daily dosage was determined freely by local standards of
Method: In a 6-week trial between December 2000
and January 2002, 1713 patients with DSM-IV schizophrenia and
related psychoses were treated with risperidone, with the dose,
daily changes in dose, and weekly changes in Brief Psychiatric
Rating Scale score documented. Cluster analysis was performed to
identify homogeneous dosing patterns among the heterogeneous
Results: Of the 6 dosing patterns identified by
cluster analysis, a 2-week titration cluster, with a starting
dose of 1.8 mg/day titrated to a maximum dose of 4.7 mg/day at
day 14, and a 1-week titration cluster, with a starting dose of
2.6 mg/day titrated to a maximum dose of 5.4 mg/day at day 7,
showed superior clinical outcomes compared with the other
clusters, in which titrations were slower and higher.
Conclusion: Our results indicate that the
current consensus regarding risperidone dosing is appropriate for
clinical practice, whereas a slower titration schedule does not
guarantee a better clinical outcome, thus emphasizing the need
for appropriate early titration.